Loading... Please wait...
EUR
- Home
- In Vivo Antibodies
- Mouse In Vivo Antibodies
- Anti-Mouse IFNAR-1 In Vivo Antibody - Low Endotoxin (IVMB0202)
Product Description
Anti-Mouse IFNAR-1 In Vivo Antibody - Low Endotoxin
Introducing the Anti-Mouse IFNAR-1 In Vivo Antibody - Low Endotoxin from Assay Genie, a highly specific monoclonal antibody designed for in vivo applications. This antibody targets the IFNAR-1 protein, a key component in interferon signaling, making it ideal for research in immunology, virology, and related fields.
With a mouse IgG1 isotype, it ensures high purity and low endotoxin levels (<1.0 EU/mg), perfect for ELISA, flow cytometry, immunoprecipitation, and other assays. Available in various sizes, it is formulated in phosphate-buffered saline for stability and efficacy. Enhance your research with this reliable and versatile antibody. IFNAR-1 is a type I interferon receptor subunit that plays a critical role in the immune response by mediating the effects of interferons. It is expressed on the surface of various cell types and is involved in the antiviral, antiproliferative, and immunomodulatory actions of interferons. By targeting IFNAR-1, this antibody helps to elucidate the pathways and mechanisms involved in interferon signaling, contributing to advancements in understanding immune responses and disease mechanisms.
| Product Name: | Anti-Mouse IFNAR-1 In Vivo Antibody - Low Endotoxin |
| Product Code: | IVMB0202 |
| Size: | 1mg, 5mg, 25mg, 50mg, 100mg |
| Clone: | MAR1-5A3 |
| Protein: | IFNAR1 |
| Product Type: | Monoclonal Antibody |
| Synonyms: | CD118, Ifar, Ifnar, Ifrc, INF-a receptor, Interferon-α/β receptor α chain precursor |
| Isotype: | Mouse IgG1 |
| Reactivity: | Mouse |
| Immunogen: | This antibody was produced by In vivo genetic immunization of IFNAR1 knockout mice with a plasmid encoding the extracellular domain of murine IFNAR1. |
| Applications: | B, ELISA, FC, IP, WB |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | ≥95% monomer by analytical SEC >95% by SDS Page |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Applications: | B, ELISA, FC, IP, WB |
| Recommended Usage: | FC The suggested concentration for clone MAR1-5A3 antibody for staining cells in flow cytometry is ≤ 2.0 µg per 106 in a volume of 100 µl or 100µl of whole blood. Titration of the reagent is recommended for optimal performance for each application. |
| Reactivity: | Mouse |
| Host Species: | Mouse |
| Specificity: | Clone MAR1-5A3 recognizes an epitope on mouse IFNAR1. |
| Antigen Distribution: | IFNAR1 and IFNAR2 are coexpressed on nearly all cells. |
| Immunogen: | This antibody was produced by In vivo genetic immunization of IFNAR1 knockout mice with a plasmid encoding the extracellular domain of murine IFNAR1. |
| Concentration: | ≥ 5.0 mg/ml |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | ≥95% monomer by analytical SEC >95% by SDS Page |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
IFNAR1 is a type I membrane protein, that in conjunction with IFNAR2, makes up the heterodimeric receptor that binds all type I IFNs, which includes IFN α and β. Binding and activation of the receptor stimulates Janus protein kinases, which leads to the phosphorylation of several other proteins, namely STAT1 and STAT2. IFNAR1 has also been shown to interact with PRMT1 and Tyrosine kinase 2. Type I IFNs are a family of cytokines that have been shown to promote anti-viral, anti-microbial, anti-tumor and autoimmune responses In vivo.
| Datasheet: | View |
| Protein: | IFNAR1 |
| Ligand/Receptor: | IFN-α |
| Mouse IgG1 Isotype Control [HKSP84] | |
|---|---|
| Clone | HKSP84 |
| Isotype | Mouse IgG1 |
| Endotoxin Level | Low Endotoxin |
Meet the team!
Shane Costigan
Territory Manager & Team Lead
Abdul Khadim
Sales Executive
| Wang et al. | Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice. | Molecular Therapy-Nucleic Acids 2023 | View Citation |
